BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 6291829)

  • 1. Clinical experience with the angiotensin converting enzyme inhibitor captopril.
    Walter NM; Whitworth JA; Kincaid-Smith P
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():117-21. PubMed ID: 6291829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
    Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
    Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of moderate to severe hypertensive patients with an orally active converting-enzyme inhibitor.
    Prins EJ; Donker AJ; Hoorntje SJ; Leenen FH; van der Hem GK
    Proc Eur Dial Transplant Assoc; 1979; 16():603-9. PubMed ID: 232914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long term treatment of resistant hypertension with captopril (author's transl)].
    Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
    Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme inhibitor treatment of hypertension in infancy and childhood.
    Sigström L; Aurell M; Jodal U
    Scand J Urol Nephrol Suppl; 1984; 79():107-9. PubMed ID: 6089308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension].
    Stanek B; Silberbauer K
    Acta Med Austriaca; 1984; 11(3-4):101-5. PubMed ID: 6089491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of captopril (Tensiomin) in patients with hypertension.
    Török E; Bíró V; Wagner M; Kósa E; Podmaniczky M; Cseh K
    Acta Physiol Hung; 1988; 72 Suppl():51-65. PubMed ID: 2908092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
    Mizuno K; Shigetomi S; Haruyama K; Matsui J; Gotho M; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin I-converting enzyme inhibition after renal transplantation.
    Grönhagen-Riska C; Fyhrquist F; Ahonen J; von Willebrand E; Häyry P
    Scand J Urol Nephrol Suppl; 1984; 79():63-7. PubMed ID: 6089320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Captopril in severe arterial hypertension of childhood (authors transl)].
    Bacri JL; Dechaux M; André JL; Gagnadoux MF; Broyer M
    Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():887-92. PubMed ID: 7036933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril and salt subtraction to treat "uncontrollable" hypertension in haemodialysis patients.
    Wauters JP; Waeber B; Brunner HR; Turini GA; Guignard JP; Gavras H
    Proc Eur Dial Transplant Assoc; 1979; 16():610-7. PubMed ID: 232915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E; Anson O; Neumann L
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
    Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin inhibitors for hypertension.
    Gavras H; Gavras I; Brunner HR
    Compr Ther; 1980 May; 6(5):14-8. PubMed ID: 6155240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of two angiotensin converting enzyme inhibitors in primary hypertension--a comparison of captopril and enalapril.
    Karlberg BE; Sjöstrand A; Ohman KP
    J Hypertens Suppl; 1986 Dec; 4(5):S432-4. PubMed ID: 3033182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
    Aberg H; Frithz G; Mörlin C
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril-associated granulocytopenia in hypertension after renal transplantation.
    Shindo K; Matsuya F; Ura T; Jodai A; Shimomae H; Kuniyoshi M; Hirose T; Kusaba Y; Saito Y
    Clin Nephrol; 1984 Dec; 22(6):314-6. PubMed ID: 6396008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril and propranolol in mild and moderate essential hypertension: preliminary report.
    Friedlander DH
    N Z Med J; 1979 Aug; 90(642):146-9. PubMed ID: 386192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.